脂肪肝
疾病
脂肪变性
医学
生物信息学
生物
病理
内科学
作者
Yansong Fu,Zhipeng Wang,Hong Qin
出处
期刊:Metabolites
[Multidisciplinary Digital Publishing Institute]
日期:2024-04-12
卷期号:14 (4): 218-218
被引量:17
标识
DOI:10.3390/metabo14040218
摘要
Metabolic-associated fatty liver disease (MAFLD), characterized primarily by hepatic steatosis, has become the most prevalent liver disease worldwide, affecting approximately two-fifths of the global population. The pathogenesis of MAFLD is extremely complex, and to date, there are no approved therapeutic drugs for clinical use. Considerable evidence indicates that various metabolic disorders play a pivotal role in the progression of MAFLD, including lipids, carbohydrates, amino acids, and micronutrients. In recent years, the medicinal properties of natural products have attracted widespread attention, and numerous studies have reported their efficacy in ameliorating metabolic disorders and subsequently alleviating MAFLD. This review aims to summarize the metabolic-associated pathological mechanisms of MAFLD, as well as the natural products that regulate metabolic pathways to alleviate MAFLD.
科研通智能强力驱动
Strongly Powered by AbleSci AI